SCDM EMEA 2020 Virtual Conference

September 14 - 16

The new decade arrives together with the promise to unleash the power of data, surfing the waves of new technologies, approaches and regulations. As the theme underlines – 2020 Shades of Clinical Data Science, together we will try find the way to surf these challenges and opportunities.

Diversity, integration and professional exchange: these will be the watchwords of the SCDM EMEA 2020 Virtual Conference; no man is an island and in this unique place, attendees will have the chance to find new solutions and connections for present and future challenges.

Enjoy the SCDM EMEA 2020 Virtual Conference with your colleagues.
Register as a group and benefit from our group discount.


Storytelling Session [ST] Roundtable Discussion [RT] Oral Presentation [OP] Panel Discussion [PD]

Wednesday, September 16
08:15 - 08:30
Highlight Day Before
08:30 - 09:00
Keynote: CDM in 2030 - What the Future Holds? [OP]
Patrick Nadolny, Allergan
09:00 - 10:00
Expert CDM forum: Risk-based Quality management in CDM [RT]
Expert CDM forum: Impact & Implementation of Real World Evidence [RT]
10:00 - 11:30
11:30 - 12:00
EMEA Closing Ceremony
12:00 - 14:00
14:00 - 15:30
Leadership Debate - Data Privacy [PD]
16:15 - 17:15
Session 25 - Increasing importance of Clinical Outcomes Assessments - Is DM ready to deal with it? [PD]
Arshad Mohammed, Covance
17:15 - 18:00
Session 31 - Movers & Shakers of Clinical Data Management - Demystifying Novel Challenges & Building Trust in AI/ML Models [PD]
Mrunalini Jagtap, Singapore Institute for Clinical Sciences (SICS), A*STAR

*Pre-registration is required and additional fees might apply.


Kent Tholke_Headshot

Kent Thoelke

Chief Scientific Officer and Executive Vice President, PRA Health Sciences

Kent Thoelke, is the Chief Scientific Officer and Executive Vice President of PRA Health Sciences, a Global Contract Research Organization. With 30 years of experience in the drug development industry, he has oversight of Medical Affairs, Scientific Affairs, and Pharmacovigilance/Patient Safety. Mr. Thoelke is also responsible for all aspects of Digital Health at PRA Health Sciences which includes, Mobile Health/Telehealth, Connected Health/Remote Patient Monitoring, EHR integration/eSource technologies, Patient Experience, and Virtual Clinical Trial Services. Mr. Thoelke is responsible for the strategic vision regarding the deployment of Clinical Research as a Care Option utilizing Virtual/Decentralized Trials, and Connected/Mobile health as a means of ensuring patient care an business continuity during the COVID19 pandemic and how these solutions will translate into the “new normal” for the drug development paradigm moving forward.

Patrick Nadolny

Associate VP, Clinical Data Management and Programming, Allergan (an Abbvie company)

Associate Vice President, Clinical Data Management and Programming Chair of SCDM Innovation Committee, Clinical Data Science advisor to the SCDM Board. Mr. Nadolny is a pragmatic leader focusing on technology, innovation, strategic planning, change management, and the setup of new capabilities. Mr. Nadolny is the Global head of Clinical Data Management and Programming at Allergan (an Abbvie company).  He supports SCDM thought leadership through the SCDM innovation committee which released reflection papers on the evolution of Clinical Data Management toward Clinical Data Science. Mr. Nadolny has 28 years of industry experience across pharmaceutical, device and biologics as well as technology solution development.  Prior to joining Allergan in 2018, Mr. Nadolny was leading PAREXEL Clinical Solutions Technologies including the market leading IMPACT® CTMS, DataLabs® EDC as well as Data System integration solutions. In 2014, Mr. Nadolny was the team Leader for the “Data Integrity and GCP Misconduct” work stream for TransCelerate and the Risk-based Monitoring Company Representative for Allergan.  He co-wrote two position papers for TransCelerate including the 2016 DIA Authors of the Year Award “Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials”.


$ 285

Member Registration
(until August 14)

Early Bird
$ 310

Member Registration
(from August 15)

$ 335

 Non-Member Registration
(until August 14)

Early Bird
$ 360

Non-Member Registration
(from August 15)

$ 285

Maximum 10 attendees

$ 185

11 – 25 attendees

$ 145

26 – 50 attendees


All costs referred to are in USD and a reference in EUR is calculated automatically based on the current exchange rate USD to EUR.

Please note that all payments are processed in USD. The amount in EUR may vary depending on exchange rate as well as on fees applied by your credit card provider for payments in a foreign currency.

During the online registration process, payments by major credit cards (American Express, VISA and MasterCard) are accepted.

Please note that SCDM does not accept conference registration fee payments by check.


They proudly support the SCDM 2020 EMEA Virtual Conference:

For more information about sponsorship opportunities, please contact Lieven Marien at [email protected].


Contact Us